slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 100,711-100,740
Pages 3,953
Rows per page 30
Component
100,711-100,740 of 118,578
01
Deliveroo | Results Presentation Deck | 5 slidesDeliveroo | Results Presentation Deck | 5 slides · Deliveroo
Conference presentation Investor relations Beat · What Is1 hit
05
Diageo | Results Presentation Deck | 39 slidesDiageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
11
Diageo | Results Presentation Deck | 39 slidesDiageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Satisfaction1 hit
29
The slide uses a house-like structure to represent the capital allocation framework.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations Beat · Action1 hit
39
This is a continuation of a methodology disclosure page.Diageo | Results Presentation Deck | 39 slides · Diageo
Conference presentation Investor relations 1 hit
103
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
107
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
109
The slide showcases three distinct marketing assets: a strategy guide, an e-book, and a technical case study/application note.D-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
112
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
122
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
123
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
124
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
125
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
126
D-Wave | Investor Day Presentation Deck | 133 slidesD-Wave | Investor Day Presentation Deck | 133 slides · D-Wave
Conference presentation Investor relations 1 hit
03
Electronic Arts | Results Presentation Deck | 17 slidesElectronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations 1 hit
08
Includes specific disclaimers regarding EPS calculation and asset impairment.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
11
The table provides a reconciliation of GAAP guidance to adjusted figures for the three months ending March 31, 2024.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
12
The table reconciles GAAP guidance ranges with specific non-GAAP adjustments.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
14
The slide provides specific FX rate assumptions for EUR, GBP, CAD, and SEK for Q3 2023, Q3 2024, and Q4E 2024, along with sensitivity analysis for a 10% USD strengthening.Electronic Arts | Results Presentation Deck | 17 slides · Electronic Arts
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
01
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
04
The slide uses a structured layout to present market data for three distinct cancer segments, including CAGR and projected market values.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Logic Chain1 hit
06
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Logic Chain1 hit
09
Scientific diagram illustrating the mechanism of antigen presentation and T cell maturation.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
10
The slide uses a biological diagram to explain the 'problem' of immune evasion in cancer therapy.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
11
The diagram uses a funnel-like or layered process flow to map biological mechanisms to specific immune outcomes.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
14
The diagram illustrates a complex supply chain process involving biopsy, manufacturing, and clinical administration.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
15
The slide uses a combination of a process diagram and dot plots to validate the model's performance.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
19
The slide presents two bar charts comparing control, tumor, tumor+mock, and tumor+TD groups under different treatment conditions (IL2 vs aCD16).Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
21
The slide demonstrates efficacy of RENB-DC11 in stimulating immune response (IFNg production) in a tumor model.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
28
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit